Navigation Links
Advance in Medical Technology

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

PITTSBURGH, July 16 /PRNewswire/ -- Cognition Therapeutics Inc., a Pittsburgh-based drug discovery company developing small molecule disease-modifying treatments for Alzheimer's, has closed on a $1.21M Series A financing. The round was led by Ogden CAP, LLC of New York City and inc...

Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases

TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for resea...

Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study

- 12-week study concludes that new cosmeceutical improves skin barrier function, erythema and lesions associated with rosacea - NAPA, Calif., May 4 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that targ...

Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3

CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced it has raised $50 million in a private equity financing. This capital will be utilized to support the ongoing Phase 3 development program evaluating linaclotide for the treatment of irritable bowel syndrome...

NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs

Total Disc Replacement implant represents newest alternative surgical treatment Dr. Carl Giordano - based in Morristown - among first surgeons selected to provide operation Dramatic reduction in post-surgery pain and stiffness; quicker ...

Portola Completes $60 Million Financing to Advance Its Therapeutic Programs

SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire/ -- Portola Pharmaceuticals, Inc., a privately-held biotechnology company focused on the discovery and development of novel therapeutics for cardiovascular and inflammatory diseases, announced today that is has raised $60 million in a preferred s...

Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies

Olympus Corporation to Support the Joint Program through the Provision of Novel Imaging Systems Collaboration Will Bring Innovative Fluorescent Imaging Agent and System Technologies into Clinical Trials in Ovarian Cancer PHILADELPHIA, TOKYO and WOBURN, Mass, J...

Continued Funding to Help Advance 'Exciting Moment' in Diabetes Research

American Diabetes Association and Richard and Susan Smith Family Foundation Announce Renewed Commitment to Diabetes Gene Study ALEXANDRIA, Va., April 30 /PRNewswire-USNewswire/ -- The American Diabetes Association (ADA) has announced research projects to study newly discovered human type 2...

Women Invited to Join New Health Registry to Advance Research

CHICAGO, March 13 /PRNewswire-USNewswire/ -- Women throughout the state are invited to help advance research in women's health by joining the new Illinois Women's Health Registry. The registry, created by the Institute for Women's Health Research at Northwestern University's Feinberg School of...

Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment

Harris Expands Enterprise Intelligence Systems to Healthcare Market ORLANDO, Fla., Feb. 25 /PRNewswire-FirstCall/ -- HIMSS, Booth #1841 -- Harris Corporation (NYSE: HRS ), an international communications and information technology company, has joined forces with Cancer Treatment Services In...

American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities

Research presented this week at American Society for Reproductive Medicine meeting could significantly improve ability to identify embryos that present high risk of birth defects or miscarriage for IVF patients AFA supports efforts to bring advanced screening technology to patients as quickly...

BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer

BRISBANE, Calif., Sept. 25 /PRNewswire/ -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapies, today announced that it has hired industry veterans Eric D. Malek as vice president of corporate development and Deborah A. Thomas as vice president fo...

NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results

SOPHIA ANTIPOLIS, France, Sept. 11 /PRNewswire/ -- NicOx S.A. (Eurolist: COX) today reported that TOPIGEN Pharmaceuticals Inc. has disclosed promising top-line results from its first phase 2 clinical study for TPI-1020, a new chemical entity licensed from NicOx which is a novel respiratory ant...

Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor

Multi-Center International Study to Determine the Efficacy of LBH589 in Patients with Relapsed or Refractory Multiple Myeloma NORWALK, Conn., Aug. 14 /PRNewswire-USNewswire/ -- The Multiple Myeloma Research Consortium (MMRC) today announced its participation in a Phase II study to dete...

Next Safety, Inc.'s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery

WEST JEFFERSON, N.C.--(BUSINESS WIRE)--Jun 15, 2007 - Next Safety, Inc. has identified basic scientific mechanisms that promise to revolutionize pulmonary drug delivery. This proprietary technology uses a stream of purified air to deliver medications deep into the pulmonary system. It is considered...

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... the future. "The implantation of this kind of device on any organ and the ability to deliver medication to the affected organ, could be a huge advance in how we currently treat cancer," Dr. Murphree said. This work is done in conjunction with Ricardo Carvalho, M.D., Ph.D. and the company 3T Ophthalmi...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... first-line treatment of patients with KRAS wild-type metastatic colorectal cancer (mCRC). "We believe that these data document an important advance for patients with metastatic colorectal cancer," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen....

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...m financial benefits that enable us to continue to advance the technology and fill the pipeline with more exc...rugs that Isis' satellite companies are developing advance in clinical development. Altair rep... Isis benefits from its partners as they advance RNA-based technologies and develop drugs that inco...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

...nts through the addition of High Dose Rate (HDR) brachytherapy. This latest advance in brachytherapy allows physicians to deliver precise radiation treatment t...y, as well as best-in-class clinical and operational processes that help to advance the quality, safety and cost effectiveness of cancer care. For more informa...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... durations of treatment and a more rapid reduction in fracture risk in the severe osteoporotic postmenopausal population, which would be a significant advance in the treatment of this debilitating disease." About the Phase 2 Clinical Trial The Phase 2 randomized, placebo- and comparator-controlled...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...ne. Nektar's technology has been shown to increase oral bioavailability and inhibit penetration across the blood-brain barrier, an important potential advance for small molecule therapies. The product is being developed to treat opioid-induced constipation (OIC). NKTR-102, PEGylated irinotecan, is cu...

DNA Helps Reunite Children With Their Families

...iving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technolo...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...ty database. Two ovarian cancer patients have been enrolled in the study to date, and it is anticipated 6 to 12 patients will be enrolled this year in advance of enrolling patients in trial evaluating ProLindac in combination with other chemotherapies. Access recently announced data from a recurrent ovarian ...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

...it is completely disposable, eliminating the very costly sterilization process commonly associated with endoscopic procedures. "We are proud to advance our visualization capabilities with Tower, the leading specialty semiconductor manufacturer and foremost CMOS image sensor provider," said Dr. Elazar ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

...nt from the spleen to inflammatory sites, including myocardial infarction. The findings are expected to open up new areas of research and potentially advance therapeutic approaches to key disease areas including inflammation and myocardial injury. In the SCIENCE report, entitled " Identification of...

New Powder Speeds Healing of Difficult Foot Wounds

...A) 97th Annual Scientific Meeting in Toronto, July 30 - August 2, 2009, and will highlight the powder's unique ability to rapidly heal foot wounds and advance the treatment patients currently receive. (Logo: http://www.newscom.com/cgi-bin/prnh/20090730/DC54472LOGO ) This wound powder is especially...

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

...in areas such as heart disease, cancer, pediatrics, transplant, and neurosciences; to create a model teaching environment for the 21st century; and to advance the health of the communities we serve." The new long-term agreement demonstrates a renewed level of commitment that will align key strategic d...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...esident R&D, Danone Research. "We hope the two young investigators will advance our knowledge in the growing field of probiotics and provide insight to bet...DANONE and Yakult Honsha Co., Ltd. The role of the GPC is to promote and/or advance probiotics in the world, through means such as: Raising awareness...

Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA

...'s ability to successfully conduct clinical development of LX1032 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain pat...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...concept study in HCV-infected patients, we plan to advance IDX184 into a 14-day dose-ranging study in combina...ibavirin, to determine the optimal IDX184 doses to advance into broader clinical trials." In the 75.... There can be no guarantees that the company will advance any clinical product candidate or other component ...

Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results

...n the lives of the 1.5 million Americans, and millions more worldwide, who suffer from this devastating autoimmune illness." "This is a major advance for patients, families, and physicians--the entire lupus community!" said Richard Furie, MD, chief of the division of rheumatology and allergy-clinica...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...evelopment with positive results. We look forward to completing the pivotal studies, with the hope of bringing this potentially important therapeutic advance to patients suffering from SLE." Key Findings from BLISS-52 "The BLISS-52 results support and extend the findings that emerged in ...

AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine

...s to maximize the potential of this platform through a mixture of in-house and partnered programs. The AlphaVax technology is currently being used to advance vaccines for cytomegalovirus, herpes simplex virus, respiratory syncytial virus, a range of cancers, influenza, HIV and a number of biodefense targets...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...st that a type-specific, quantitative PCR-MS based test may be an important advance in the early detection of cervical cancer." Study Methodology ...ion that a type specific quantitative PCR-MS based test may be an important advance in the early detection of cervical cancer, the future prospects and potenti...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...an in early 2000 (nearly 400 patients), a panel of experts strongly endorses moving forward to complete the final phase of clinical trials (MARVEL) to advance muscle stem cell (myoblast) therapy for treating heart failure to mainstream use with FDA approval and CMS reimbursement. The MARVEL II program aims ...

MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants

...tting During First Year of Life; Reinforcing Commitment to Pediatric Research GAITHERSBURG, Md., June 29 /PRNewswire/ -- MedImmune continues to advance its commitment to pediatric research with today's announcement of the first observational prospective study designed to assess the burden of respirato...

Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases

...istant depression and approved by a multi-disciplinary team." Ongoing advances in DBS technologies represent an important new field that could greatly advance the understanding of psychiatric neurobiology, according to the review. A peer-review journal, Mayo Clinic Proceedings publishes original article...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

...r, anesthesiologist Dr. Neil Singla, CEO of Lotus Clinical Research Inc., Pasadena, CA, stated, "The ARX-01 product has the potential to offer a major advance in the management of inpatient acute pain, liberating patients from the IV connection to a PCA pump, while still providing effective pain control appr...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia

...es of VA106483. The trial involved 27 elderly men aged 65 years or more with a history of nocturia. Based on these results, Vantia now plans to advance VA106483 into a larger Phase IIb clinical efficacy study in the second half of 2009. Dr Jim Phillips, CEO of Vantia Therapeutics, said 'VA10648...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

...rd-looking statements include dependence on King's ability to conduct its presentations as planned; dependence on the Company's ability to continue to advance the development of its pipeline products as planned; dependence on the high cost and uncertainty of research, clinical trials, and other development a...
Other Tags
(Date:7/10/2014)... a whole fresh avocado with either an orange-colored tomato ... (alpha- and beta-carotene) absorption and conversion of these carotenoids ... new research (1) published in The Journal ... is involved in reproductive health and growth promotion; helps ... antioxidant properties. Provitamin A carotenoids, like alpha- and beta-carotene, ...
(Date:7/9/2014)... PA, July 10, 2014 Inflammatory diseases can ... patient, complicating treatment because a medication effective for ... example is the anti-arthritic medication dexamethasone, which alleviates ... A study in the August issue of ... effects of a new class of anti-arthritic drugs, ...
(Date:7/9/2014)... to switch out one gene for another in a ... science fiction to reality within this decade. As with ... hope of fixing disease-causing genes in humans, for example--as ... have put one of those concerns to rest: using ... occurrence of mutations in the cells. The new results ...
Breaking Biology News(10 mins):New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2New class of anti-arthritis drugs effectively treats multiple inflammatory diseases 2No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3
(Date:7/10/2014)... of the top public health concerns in the United ... as obese as of 2012. As health problems such ... to Twitter to discuss the problem. , A new ... at the Brown School at Washington University in St. ... tweets to track Twitter conversations about the issue of ...
(Date:7/10/2014)... EAST LANSING, Mich. For those students looking to ... answer may not be spending more time in a ... New Michigan State University research shows that students who ... on MSU,s campus during their freshman and sophomore years ... The research also indicated that students with memberships stayed ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... A neuroscientist at Rutgers University-Newark says the human brain ... a finding that could provide a better understanding ... conditions that afflict an estimated 13.6 million Americans. , ... , Michael Cole, an assistant professor at the Center ... brain architecture of a person at rest is basically ...
(Date:7/10/2014)... the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan ... patients a new therapeutic combination to combat resistant sarcomas. ... treatment could stabilize the growth of these tumors have ... of Cancer ., Sarcomas , Sarcomas are a ... several subtypes. It can affect from children to older ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Want a higher GPA in college? Join a gym 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:Working to loosen the grip of severe mental illness 2Health News:New therapeutic combination to slow resistant sarcomas 2
Other Contents